glyvis
glyvis keeps losing plot functions as the packages behind them get reorganized.
A side-by-side editorial comparison of glyenzy and qqman — release velocity, themes, recent moves, and the top alternatives to consider.
Glycan biosynthesis as a traceable enzyme graph, now including sulfation and gaps it can bridge.
glyenzy infers which enzymes could have produced a glycan and traces biosynthetic routes to it, backed by curated per-enzyme rules for human glycosyltransferases and, since 0.7.0, twelve sulfotransferases. Biosynthesis functions return typed network objects that keep their igraph interface while supporting layered DAG plots with glycan nodes and labelled enzyme edges. Where no concrete enzyme covers a step, bounded virtual transitions bridge the gap and are marked so users can see which edges are inferred rather than enzymatic.
The Manhattan-plot package for GWAS results, finished and dormant since 2017.
qqman does two things: manhattan() and qq() plots for genome-wide association study results. Its six visible releases run from 2014 to a single 2017 packaging fix, and the last release with any user-facing change shipped in 2015. The archive is non-monotonic — a 0.0.0 tag published after 0.1.1 archives the pre-package standalone script — so version order and publication order disagree.
glyenzy infers which enzymes could have produced a glycan and traces biosynthetic routes to it, backed by curated per-enzyme rules for human glycosyltransferases and, since 0.7.0, twelve sulfotransferases. Biosynthesis functions return typed network objects that keep their igraph interface while supporting layered DAG plots with glycan nodes and labelled enzyme edges. Where no concrete enzyme covers a step, bounded virtual transitions bridge the gap and are marked so users can see which edges are inferred rather than enzymatic.
Two kinds of release alternate here. One is enzyme curation, a steady stream of rule corrections for the FUT, MAN1A and MGAT families and removals where an enzyme turned out to act only on glycolipids, which is the unglamorous accuracy work a rule-based inference engine lives on. The other is turning biosynthesis output into a first-class object: paths became networks, networks became typed with plotting support, and targets became a marked vertex attribute. The package moves in lockstep with its siblings, pinning glyrepr 0.13.0 and glymotif 0.17.0 as those refreshed their data and matching APIs, and the latest release already speaks glydraw 0.8.0's orientation values.
The paucimannose N-glycan support dropped in 0.7.0 is the obvious loose end, with users told to stay on 0.6.3, so a reinstated implementation is a plausible next move. Beyond that the virtual-step machinery is new enough that its heuristics, particularly the inferred step limits added in 0.8.1, should keep being tuned.
qqman does two things: manhattan() and qq() plots for genome-wide association study results. Its six visible releases run from 2014 to a single 2017 packaging fix, and the last release with any user-facing change shipped in 2015. The archive is non-monotonic — a 0.0.0 tag published after 0.1.1 archives the pre-package standalone script — so version order and publication order disagree.
The real development window was 2014 to 2015. The 0.1.2 release did the substantive work, replacing the assumption that SNPs are evenly distributed across chromosomes and handing users control of axis limits, labels and log transformation; 0.1.3 then added annotation by p-value threshold and top-SNP-per-chromosome. After that the package stops. Notably, the archival 0.0.0 entry records that the original script had confidence intervals on QQ plots and richer highlighting than the released package ever regained.
With one packaging fix in the last decade, these entries support no prediction of further releases. The package reads as complete for its narrow purpose rather than abandoned mid-arc.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either glyenzy or qqman.
glyvis keeps losing plot functions as the packages behind them get reorganized.
glysmith turns an LLM interview into a reproducible glycomics analysis pipeline.
glyfun is three releases old and has spent all of them chasing glyexp's container change.
glydet is rebuilding its glycan trait vocabulary on top of someone else's container.
glyexp is retiring its own data container and handing the job to Bioconductor.
A glycan motif matcher trading convenience wrappers for speed, strictness and explicit specs.
See all glyenzy alternatives → · See all qqman alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. glyenzy is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. glyenzy is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top glyenzy alternatives in Analytics are ranked by recent ship velocity. Browse the "glyenzy alternatives" section above for the current picks, or visit /alternatives/glyenzy for the full list with editorial commentary on each.
Top qqman alternatives in Analytics are ranked by recent ship velocity. Browse the "qqman alternatives" section above for the current picks, or visit /alternatives/qqman-r for the full list with editorial commentary on each.